Malignant Hematology Team
Physicians looking to refer a patient to experienced malignant hematology specialists can consider the many advantages of receiving treatment at Moffitt Cancer Center. Led by Jeffrey Lancet, MD, the team that makes up our Malignant Hematology Program focuses exclusively on the diagnosis and treatment of different blood cancers and autoimmune disorders. Our program’s survival rates are better than the national averages, and as a high-volume cancer center, our malignant hematology specialists have a unique level of experience treating patients with conditions like:
- Leukemia
- Lymphoma
- Myelodysplastic syndromes (MDS)
- Myeloproliferative syndromes
- Multiple myeloma
- Aplastic anemia
- Other hematological malignancies
Individualized treatment plans from our malignant hematology specialists
When a patient is referred to Moffitt, we will provide a complete diagnostic workup, including staging and pathology services, to get a full picture of the patient’s condition. Then, our malignant hematology specialists – including medical oncologists, hematopathologists and others – will review his or her case to ensure we provide an individualized treatment plan that will give the patient the best chance at reaching a favorable outcome and an improved quality of life. Depending on the specifics of a patient’s malignancy, a treatment plan may consist of a combination of the following:
- Chemotherapy
- Immunotherapy
- Bone marrow transplantation
- Anti-angiogenesis therapy
- Promising clinical trials for eligible patients
At Moffitt, our focus extends beyond clinical treatment. We also tend to our patients’ quality of life. That’s why our patients have access to pain management specialists, dietitians, counselors and other supportive care professionals to help them cope with the challenges of undergoing cancer treatment.
Moffitt welcomes referrals for patients with a confirmed diagnosis as well as those with suspected hematologic conditions. To refer a patient to the malignant hematology specialists at Moffitt, health care providers can complete our online form or contact a physician liaison for assistance or support. We aim to make referral times as short as possible.
Â
Â
-
Malignant Hematology Leadership
Department Chair, Malignant HematologyProgram Lead, Malignant HematologyProgram
Malignant Hematology
Title
Chair, Department of Malignant Hematology
Specialty
Hematology
5 (141)
Program
Malignant Hematology
Title
Vice Chair, Department of Malignant Hematology
Specialty
Hematology/Oncology
4.9 (205)
-
Medical Oncology
Department Chair, Malignant Hematology and Cellular Therapy at Memorial Healthcare SystemProgram Lead, Malignant Hematology and Cellular Therapy at Memorial Healthcare SystemProgram
Malignant Hematology and Cellular Therapy at Memorial Healthcare System
Title
Chair, Malignant Hematology and Cellular Therapy at Memorial Healthcare System
Specialty
Medical Oncology
-
Hematology/Oncology
Program
Malignant Hematology and Cellular Therapy at Memorial Healthcare System
Specialty
Hematology/Oncology
Program
Malignant Hematology
Title
Vice Chair, Department of Malignant Hematology
Specialty
Hematology/Oncology
4.9 (205)
Program
Malignant Hematology and Cellular Therapy at Memorial Healthcare System
Specialty
Hematology/Oncology
Program
Malignant Hematology and Cellular Therapy at Memorial Healthcare System
Specialty
Hematology/Oncology
Program
Malignant Hematology and Cellular Therapy at Memorial Healthcare System
Specialty
Hematology/Oncology
Program
Malignant Hematology and Cellular Therapy at Memorial Healthcare System
Specialty
Hematology/Oncology
Program
Malignant Hematology and Cellular Therapy at Memorial Healthcare System
Specialty
Hematology/Oncology
Program
Malignant Hematology and Cellular Therapy at Memorial Healthcare System
Specialty
Hematology/Oncology
-
Hematology
Department Chair, Malignant HematologyProgram Lead, Malignant Hematology
Program
Malignant Hematology
Title
Chair, Department of Malignant Hematology
Specialty
Hematology
5 (141)
Malignant Hematology Program